Ken Griffin’s EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share EQHA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-172,169
Closed -$14K 15945
2022
Q3
$14K Sell
172,169
-8,820
-5% -$895 ﹤0.01% 12193
2022
Q2
$17K Sell
180,989
-7,471
-4% -$1.55K ﹤0.01% 12471
2022
Q1
$65K Sell
188,460
-28,980
-13% -$10.6K ﹤0.01% 12630
2021
Q4
$113K Sell
217,440
-13,303
-6% -$7.58K ﹤0.01% 12598
2021
Q3
$134K Buy
230,743
+170,743
+285% +$108K ﹤0.01% 12510
2021
Q2
$43K Hold
60,000
﹤0.01% 13396
2021
Q1
$30K Buy
+60,000
New +$34.7K ﹤0.01% 13032

Other funds holding EQHA.WS

Ken Griffin's EQHA.WS Position: Q4 2022 in Review

Ken Griffin sold out of EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) in Q4 2022, closing a stake of 172,169 shares — an estimated $14K sold.

Ken Griffin first reported a position in EQHA.WS in Q1 2021 and held it in 7 quarters. The position peaked at $134K in Q3 2021. 1 fund tracked by Wall St. Rank holds EQHA.WS as of Q4 2022.

  • Ken Griffin reported no remaining EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
  • Ken Griffin sold 172,169 EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q4 2022, an estimated $14K.
  • Ken Griffin first reported a position in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q1 2021 and held it in 7 quarters.
  • Ken Griffin's EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $134K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.